SALA, GESSICA
 Distribuzione geografica
Continente #
NA - Nord America 9.097
EU - Europa 5.004
AS - Asia 4.331
SA - Sud America 704
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 19.230
Nazione #
US - Stati Uniti d'America 8.877
SG - Singapore 1.608
CN - Cina 1.156
IT - Italia 1.131
DE - Germania 802
RU - Federazione Russa 704
SE - Svezia 612
BR - Brasile 574
HK - Hong Kong 539
VN - Vietnam 450
IE - Irlanda 398
UA - Ucraina 314
GB - Regno Unito 302
CA - Canada 150
AT - Austria 146
IN - India 146
FI - Finlandia 142
FR - Francia 110
PL - Polonia 86
KR - Corea 72
NL - Olanda 66
ID - Indonesia 54
AR - Argentina 52
JP - Giappone 52
TR - Turchia 51
MX - Messico 50
DK - Danimarca 48
BE - Belgio 42
BD - Bangladesh 39
IR - Iran 39
ES - Italia 35
IQ - Iraq 31
ZA - Sudafrica 26
EC - Ecuador 22
EG - Egitto 15
PK - Pakistan 15
LT - Lituania 13
CO - Colombia 12
SA - Arabia Saudita 12
VE - Venezuela 12
KE - Kenya 11
CZ - Repubblica Ceca 10
CH - Svizzera 9
EU - Europa 9
UZ - Uzbekistan 9
IL - Israele 8
PE - Perù 8
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
MA - Marocco 7
PY - Paraguay 7
TW - Taiwan 7
DZ - Algeria 5
GR - Grecia 5
JM - Giamaica 5
JO - Giordania 5
MY - Malesia 5
RO - Romania 5
UY - Uruguay 5
BO - Bolivia 4
ET - Etiopia 4
PH - Filippine 4
CI - Costa d'Avorio 3
HU - Ungheria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MU - Mauritius 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 19.223
Città #
Ann Arbor 1.609
Singapore 988
Ashburn 855
Woodbridge 679
Chandler 545
Hong Kong 532
Frankfurt am Main 504
Houston 497
Fairfield 392
Dublin 382
Milan 371
Jacksonville 345
Wilmington 321
New York 267
Dearborn 263
Santa Clara 249
Dallas 246
Beijing 179
Seattle 172
Los Angeles 156
Princeton 152
Ho Chi Minh City 146
Cambridge 137
Vienna 129
Shanghai 111
Hefei 106
Nanjing 94
Hanoi 92
Boardman 70
The Dalles 65
São Paulo 62
Lachine 61
Buffalo 59
Moscow 56
Munich 54
Altamura 53
Seoul 53
Guangzhou 50
Lawrence 47
Jakarta 46
Kraków 44
Chicago 42
Brussels 41
Helsinki 39
Fremont 36
Rome 36
London 35
Shenyang 33
Changsha 32
Pisa 32
Tokyo 31
Council Bluffs 28
Nanchang 28
San Diego 28
Turku 28
Tianjin 27
Warsaw 27
Dong Ket 26
Jinan 25
Andover 24
Turin 24
Toronto 23
Zhengzhou 23
Falls Church 22
Hebei 22
Grafing 21
Monza 21
Ottawa 21
Pune 21
Denver 20
Orem 20
Rio de Janeiro 20
Jiaxing 19
Lecco 19
Poplar 19
Montreal 18
Phoenix 18
San Francisco 18
Stockholm 18
Atlanta 17
Chennai 17
Belo Horizonte 16
Johannesburg 16
Ningbo 16
Tehran 16
Biên Hòa 15
Brooklyn 15
Da Nang 14
Mexico City 14
Amsterdam 13
Manchester 13
Nuremberg 13
Boston 12
Buenos Aires 12
Haiphong 12
Lappeenranta 12
Mountain View 12
Columbus 11
Hangzhou 11
Norwalk 11
Totale 12.512
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 570
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 448
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 412
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 380
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 370
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 351
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 339
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 322
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 319
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 300
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 297
Reduced platelet glutamate uptake in Parkinson's disease 294
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 291
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 289
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 278
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 274
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 272
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 270
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 268
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 266
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 261
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 254
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 251
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 251
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 251
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 250
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 248
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 247
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 247
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 243
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 243
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 243
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 243
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 237
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 235
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 234
New insights into the genetic etiology of Alzheimer's disease and related dementias 234
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 232
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 232
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 232
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 231
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 229
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 228
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 225
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 224
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 223
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 221
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 219
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 219
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 217
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 217
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 217
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 217
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 215
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 214
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 213
the MonzALS collaborative network 209
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 206
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 198
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 196
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 194
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 193
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 191
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 181
Macroautophagy is not altered in ALS lymphomonocytes 181
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 180
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 179
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 173
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 170
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 170
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 158
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 156
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 155
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 154
Assessing glutamatergic function and dysfunction in peripheral tissues 150
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 148
Whole-blood global DNA methylation and phenotypic variability in ALS 147
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 144
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 143
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 135
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 132
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 127
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 113
Platelets 112
Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC) 41
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 28
Totale 19.671
Categoria #
all - tutte 62.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021892 0 0 0 0 0 81 134 131 132 173 98 143
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20253.377 170 407 276 135 253 185 161 139 318 549 278 506
2025/20264.681 1.107 571 689 934 1.000 380 0 0 0 0 0 0
Totale 19.671